Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00550134 · ClinicalTrials.gov registry record
Cognitive Changes Associated With Breast Cancer Treatment
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 53
- Enrollment target
NCT00550134: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00550134 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00550134 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
Patients with cancer often complain that their "mind does not seem to be clear." This can be due to stress, depression, anxiety, or physical problems caused by cancer or the treatments used to control symptoms. There are many purposes for this study; one of them is to learn about the effects of cancer treatments on the brain, and another is to identify useful tools to detect these effects. The results of this study may stimulate new research comparing different treatments to the current treatment so the researchers may learn how to treat symptoms more effectively and improve patient quality of life. We would also like to learn more about the effects chemotherapy may have on DNA.
Interventions
- BEHAVIORAL Questionnaires, MRI, Comet assay and Cell senescence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2007-10-24 |
| Est. Completion | 2021-12-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00550134
The ClinicalTrials.gov registry entry for NCT00550134 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires, MRI, Comet assay and Cell senescence is the first listed.
NCT00550134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00550134 about?
NCT00550134 is a clinical study titled "Cognitive Changes Associated With Breast Cancer Treatment". Patients with cancer often complain that their "mind does not seem to be clear." This can be due to stress, depression, anxiety, or physical problems caused by cancer or the treatments used to control symptoms. There are many purposes for this study; one of them is to learn about the effects of canc...
What is the current status of trial NCT00550134?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2007-10-24. Estimated completion is 2021-12-28.
What interventions are being tested in trial NCT00550134?
The interventions under investigation include: Questionnaires, MRI, Comet assay and Cell senescence (BEHAVIORAL).
Who is sponsoring clinical trial NCT00550134?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.